These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1050 related items for PubMed ID: 26184135

  • 1. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
    Nath N, Chattopadhyay M, Rodes DB, Nazarenko A, Kodela R, Kashfi K.
    Molecules; 2015 Jul 09; 20(7):12481-99. PubMed ID: 26184135
    [Abstract] [Full Text] [Related]

  • 2. Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo.
    Chattopadhyay M, Kodela R, Nath N, Barsegian A, Boring D, Kashfi K.
    Biochem Pharmacol; 2012 Mar 15; 83(6):723-32. PubMed ID: 22209867
    [Abstract] [Full Text] [Related]

  • 3. Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer.
    Singh S, Shi Q, Bailey ST, Palczewski MJ, Pardee AB, Iglehart JD, Biswas DK.
    Mol Cancer Ther; 2007 Jul 15; 6(7):1973-82. PubMed ID: 17620428
    [Abstract] [Full Text] [Related]

  • 4. NOSH-aspirin (NBS-1120) inhibits pancreatic cancer cell growth in a xenograft mouse model: Modulation of FoxM1, p53, NF-κB, iNOS, caspase-3 and ROS.
    Chattopadhyay M, Kodela R, Santiago G, Le TTC, Nath N, Kashfi K.
    Biochem Pharmacol; 2020 Jun 15; 176():113857. PubMed ID: 32061771
    [Abstract] [Full Text] [Related]

  • 5. NOSH-aspirin (NBS-1120) inhibits estrogen receptor negative breast cancer in vitro and in vivo by modulating redox-sensitive signaling pathways.
    Chattopadhyay M, Nath N, Kodela R, Metkar S, Soyemi SA, Kashfi K.
    J Pharmacol Exp Ther; 2024 Jun 27. PubMed ID: 38936976
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
    Matsumoto G, Namekawa J, Muta M, Nakamura T, Bando H, Tohyama K, Toi M, Umezawa K.
    Clin Cancer Res; 2005 Feb 01; 11(3):1287-93. PubMed ID: 15709200
    [Abstract] [Full Text] [Related]

  • 8. Celecoxib induced apoptosis against different breast cancer cell lines by down-regulated NF-κB pathway.
    Wang G, Li J, Zhang L, Huang S, Zhao X, Zhao X.
    Biochem Biophys Res Commun; 2017 Aug 26; 490(3):969-976. PubMed ID: 28666869
    [Abstract] [Full Text] [Related]

  • 9. Nitro-aspirin inhibits MCF-7 breast cancer cell growth: effects on COX-2 expression and Wnt/beta-catenin/TCF-4 signaling.
    Nath N, Vassell R, Chattopadhyay M, Kogan M, Kashfi K.
    Biochem Pharmacol; 2009 Nov 15; 78(10):1298-304. PubMed ID: 19576865
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
    Jiang J, Slivova V, Sliva D.
    Int J Oncol; 2006 Sep 15; 29(3):695-703. PubMed ID: 16865287
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anticancer effects of wogonin in both estrogen receptor-positive and -negative human breast cancer cell lines in vitro and in nude mice xenografts.
    Chung H, Jung YM, Shin DH, Lee JY, Oh MY, Kim HJ, Jang KS, Jeon SJ, Son KH, Kong G.
    Int J Cancer; 2008 Feb 15; 122(4):816-22. PubMed ID: 17957784
    [Abstract] [Full Text] [Related]

  • 15. Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF-κB and p53.
    Zhang Y, Wu J, Jing H, Huang G, Sun Z, Xu S.
    J Cell Biochem; 2019 Apr 15; 120(4):6789-6797. PubMed ID: 30556250
    [Abstract] [Full Text] [Related]

  • 16. Ganoderic acids suppress growth and angiogenesis by modulating the NF-κB signaling pathway in breast cancer cells.
    Li F, Wang Y, Wang X, Li J, Cui H, Niu M.
    Int J Clin Pharmacol Ther; 2012 Oct 15; 50(10):712-21. PubMed ID: 22762853
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lycopene acts through inhibition of IκB kinase to suppress NF-κB signaling in human prostate and breast cancer cells.
    Assar EA, Vidalle MC, Chopra M, Hafizi S.
    Tumour Biol; 2016 Jul 15; 37(7):9375-85. PubMed ID: 26779636
    [Abstract] [Full Text] [Related]

  • 19. A new IkappaB kinase beta inhibitor prevents human breast cancer progression through negative regulation of cell cycle transition.
    Tanaka A, Muto S, Konno M, Itai A, Matsuda H.
    Cancer Res; 2006 Jan 01; 66(1):419-26. PubMed ID: 16397257
    [Abstract] [Full Text] [Related]

  • 20. CD24 enhances DNA damage-induced apoptosis by modulating NF-κB signaling in CD44-expressing breast cancer cells.
    Ju JH, Jang K, Lee KM, Kim M, Kim J, Yi JY, Noh DY, Shin I.
    Carcinogenesis; 2011 Oct 01; 32(10):1474-83. PubMed ID: 21798852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.